Skip to main content
. Author manuscript; available in PMC: 2024 May 20.
Published in final edited form as: J Pediatr. 2018 Sep 26;203:371–379.e7. doi: 10.1016/j.jpeds.2018.07.060

Table II.

Mortality by diagnosis and age

CCHD types n Year 1
Years 2-5
Years 6-10
Deaths (%) n Deaths (%) n Deaths (%)
Overall 1439 208 (14.5) 944 25 (2.6) 480 8   (1.7)
HLHS   225   85 (37.8)   97   5 (5.2)   38 3   (7.9)
TA  80   14 (17.5)   50   0 (0.0)  5 0   (0.0)
Other SVs  24  4 (16.7)   17   0 (0.0)   29 0   (0.0)
PA/IVS  33  5 (15.2)   21   2 (9.5)  7 1 (14.3)
Truncus  49   13 (27.1)   26   2 (7.7)   12 1   (8.3)
Ebstein anomaly  47  9 (19.1)   26   2 (7.7)  8 0   (0.0)
PA/VSD  66   13 (19.7)   42   3 (7.1)   13 0   (0.0)
DORV/TGA  31  2   (6.5)   22   1 (4.5)   12 1   (8.3)
DTGA   135  8   (6.0)   98   0 (0.0)   63 0   (0.0)
TOF   192   18   (9.4) 140   5 (3.6)   79 1   (1.3)
DORV  20  3 (15.0)   13   1 (7.7)  6 0   (0.0)
IAA  31  4 (12.9)   23   1 (4.3)   13 0   (0.0)
TAPVR  49  6 (12.2)   31   0 (0.0)   13 0   (0.0)
Coarctation   461   24   (5.2) 338   3 (0.9) 182 1   (0.5)

Coarctation, coarctation of the aorta; DTGA, d-transposition of the great arteries; IAA, interrupted aortic arch; SVs, single ventricles; TA, tricuspid atresia; TAPVR, total anomalous pulmonary venous return.